Skip to main content

Advertisement

SpringerLink
Log in

Effect of nepafenac on the foveal profile of glaucomatous patients undergoing phacoemulsification

  • Original Paper
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

Retrospective, pilot study to determine whether nepafenac treatment pre- and postcataract surgery in glaucoma patients using topical hypotensive agents minimized cystoid macular edema by comparing pre- and postsurgical foveal characteristics, as in some cases these agents cannot be withdrawn and, hypothetically, their inflammatory effect on the fovea could be neutralized by the addition of nepafenac.

Methods

Patients were divided into two subgroups depending on whether or not topical nepafenac was added to the surgical protocol (NEP = nepafenac group and nNEP = non nepafenac group). All had undergone phacoemulsification and data on pre- and postoperative macular status were recorded.

Results

In the nNEP group, there was a significant increase in foveal thickness (FT) in the first month postoperative visit with respect to the preoperative status (p = 0.006), and this situation did not change at the third postoperative month (p = 0.9411). In the NEP group, the increase in FT was not significant at the first month after surgery (p = 0.056) nor at the final visit (p = 0.268), in contrast to the nNEP group.

Conclusion

This study of the possible prophylactic effect of nepafenac on postoperative macular edema supports the results of other studies that confirm subclinical edema post phacoemulsification, and found a significantly lower gradient in the increase in FT in patients treated pre- and postoperatively with nepafenac.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Irvine SR (1953) A newly defined vitreous syndrome following cataract surgery. Am J Ophthalmol 36:599–619

    Article  CAS  PubMed  Google Scholar 

  2. Gass JD, Norton EW (1969) Follow-up study of cystoid macular edema following cataract extraction. Trans Am Acad Ophthalmol Otolaryngol 73:665–682

    CAS  PubMed  Google Scholar 

  3. Von Jagow B, Ohrloff C, Kohnen T (2007) Macular thickness after uneventful cataract surgery determined by optical coherence tomography. Graefes Arch Clin Exp Ophthalmol 245:1765–1771

    Article  Google Scholar 

  4. Biro Z, Balla Z, Kovacs B (2008) Change of foveal and perifoveal thickness measured by OCT after phacoemulsification and IOL implantation. Eye (Lond). 22:8–12

    Article  CAS  PubMed  Google Scholar 

  5. Ursell PG, Spalton DJ, Whitcup SM, Nussenblatt RB (1999) Cystoid macular edema after phacoemulsification: relationship to blood-aqueous barrier damage and visual acuity. J Cataract Refract Surg 25:1492–1497

    Article  CAS  PubMed  Google Scholar 

  6. Lobo CL, Faria PM, Soares MA, Bernardes RC, Cunha-Vaz JG (2004) Macular alterations after small-incision cataract surgery. J Cataract Refract Surg 30:752–760

    Article  PubMed  Google Scholar 

  7. Wright PL, Wilkinson CP, Balyeat HD et al (1988) Angiographic cystoid macular edema after posterior chamber lens implantation. Arch Ophthalmol 106:740–744

    Article  CAS  PubMed  Google Scholar 

  8. Cataract in the adult eye. Preferred Practice Pattern, American Academy of Ophthalmology (2011)

  9. Ray S, D’Amico DJ (2002) Pseudophakic cystoid macular edema. Semin Ophthalmol. 17:167–180

    Article  PubMed  Google Scholar 

  10. Vukicevic M, Gin T, Al-Qureshi S (2012) Prevalence of optical coherence tomography-diagnosed postoperative cystoid macular oedema in patients following uncomplicated phacoemulsification cataract surgery. Clin Experiment Ophthalmol. 40:282–287

    Article  PubMed  Google Scholar 

  11. Kusbeci T, Eryigit L, Yavas G, Inan UU (2012) Evaluation of cystoid macular edema using optical coherence tomography and fundus fluorescein angiography after uncomplicated phacoemulsification surgery. Curr Eye Res 37:327–333

    Article  PubMed  Google Scholar 

  12. Bertelmann T, Witteborn M, Mennel S (2012) Pseudophakic cystoid macular oedema. Klin Monbl Augenheilkd. 229(8):798–811

    Article  CAS  PubMed  Google Scholar 

  13. Yasuda K, Miyazawa A, Shimura M (2012) A comparison of preservative-free diclofenac and preserved diclofenac eye drops after cataract surgery in patients with diabetic retinopathy. J Ocul PharmacolTher. 28(3):283–289

    Article  CAS  Google Scholar 

  14. Thomas JV, Gragoudas ES, Blair NP, Lapus JV (1978) Correlation of epinephrine use and macular edema in aphakic glaucomatous eyes. Arch Ophthalmol 96:625–628

    Article  CAS  PubMed  Google Scholar 

  15. Hesse RJ, Swan JL 2nd (1988) Aphakic cystoid macular edema secondary to betaxolol therapy. Ophthalmic Surg. 19(8):562–564

    CAS  PubMed  Google Scholar 

  16. Makri OE, Georgalas I, Georgakopoulos CD (2013) Drug-induced macular edema. Drugs. 73:789–802

    Article  CAS  PubMed  Google Scholar 

  17. Yeh PC, Ramanathan S (2002) Latanoprost and clinically significant cystoid macular edema after uneventful phacoemulsification with intraocular lens implantation. J Cataract Refract Surg 28:1814–1818

    Article  PubMed  Google Scholar 

  18. Moroi SE, Gottfredsdottir MS, Schteingart MT, Elner SG, Lee CM, Schertzer RM, Abrams GW, Johnson MW (1999) Cystoid macular edema associated with latanoprost therapy in a case series of patients with glaucoma and ocular hypertension. Ophthalmology 106(5):1024–1029

    Article  CAS  PubMed  Google Scholar 

  19. Miyake K, Nobuhiro I, Yoko G et al (2003) ESCRS Binkhorst lecture 2002: pseudophakic preservative maculopathy. J Cataract Refract Surg 29:1800–1810

    Article  PubMed  Google Scholar 

  20. Goto Y, Ibaraki N, Miyake K (2003) Human lens epithelial cell damage and stimulation of their secretion of chemical mediators by benzalkonium chloride rather than latanoprost and timolol. Arch Ophthalmol 121:835–839

    Article  CAS  PubMed  Google Scholar 

  21. Miyake K, Ibaraki N (2002) Prostaglandins and cystoid macular edema. Surv Ophthalmol 47(Suppl 1):S203–S218

    Article  PubMed  Google Scholar 

  22. Abe RY, Zacchia RS, Santana PR, Costa VP (2014) Effects of benzalkonium chloride on the blood-aqueous and blood-retinal barriers of pseudophakic eyes. J Ocul Pharmacol Ther 30(5):413–418

    Article  CAS  PubMed  Google Scholar 

  23. Asano S, Miyake K, Ota I, Sugita G, Kimura W, Sakka Y, Yabe N (2008) Reducing angiographic cystoid macular edema and blood-aqueous barrier disruption after small-incision phacoemulsification and foldable intraocular lens implantation: multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethasone 0.1%. J Cataract Refract Surg 34:57–63

    Article  PubMed  Google Scholar 

  24. Miyake K, Ota I, Miyake G, Numaga J (2011) Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery. J Cataract Refract Surg 37:1581–1588

    Article  PubMed  Google Scholar 

  25. Wang QW, Yao K, Xu W, Chen PQ, Shentu XC, Xie X, Weng Y, Zhang L, Jin CF, Wu W, Zhu YN, Yu YH (2013) Bromfenac sodium 0.1%, fluorometholone 0.1% and dexamethasone 0.1% for control of ocular inflammation and prevention of cystoid macular edema after phacoemulsification. Ophthalmologica 229:187–194

    Article  CAS  PubMed  Google Scholar 

  26. Alm A, Grieson I, Shields MB (2008) Side effects associated with prostaglandin analog therapy. Survey Ophthalmol 53(Suppl 1):S93–105

    Article  Google Scholar 

  27. Chang JH, McCluskey P, Missotten T, Ferrante P, Jalaludin B, Lightman S (2008) Use of ocular hypotensive prostaglandin analogues in patients with uveitis: does their use increase anterior uveitis and cystoid macular oedema? Br J Ophthalmol 92(7):916–921

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Glaucoma Unit, Ophthalmology Department, Hospital Clínic de Barcelona, Sabino Arana, 1, 08028, Barcelona, Spain

    Elena Milla

  2. Glaucoma Unit, Institut Comtal d’Oftalmologia, Barcelona, Spain

    Elena Milla, Oana Stirbu & Susana Duch

  3. Glaucoma Unit, Ophthalmology Department, Complejo Asistencial Universitario de Salamanca, Salamanca, Spain

    Isabel Jimenez Franco & Santiago J. García Hernández

  4. Statistics Department, Hospital Clinic, Barcelona, Spain

    Jose Rios

Authors
  1. Elena Milla
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Oana Stirbu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Isabel Jimenez Franco
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Santiago J. García Hernández
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jose Rios
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Susana Duch
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elena Milla.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Milla, E., Stirbu, O., Franco, I.J. et al. Effect of nepafenac on the foveal profile of glaucomatous patients undergoing phacoemulsification. Int Ophthalmol 37, 1147–1153 (2017). https://doi.org/10.1007/s10792-016-0381-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-016-0381-6

Keywords

Search

Navigation